According to the guidelines for the management of primary lung cancer (The General Office of the National Health and Health Commission, 2022), chemotherapy (etoposide combined with carboplatin or cisplatin) in combination with a PD-L1 inhibitor is recommended as the first-line treatment for patients with ES-SCLC. This evidence concerns the gene CD274 and lung cancer.